Page last updated: 2024-12-05
3-chloroacetanilide
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 11493 |
| SCHEMBL ID | 357999 |
| MeSH ID | M0230131 |
Synonyms (44)
| Synonym |
|---|
| m-chloroacetanilide |
| acetanilide, 3'-chloro- |
| nsc6116 |
| acetamide, n-(3-chlorophenyl)- |
| 3-chloroacetanilide |
| 3'-chloroacetanilide |
| 588-07-8 |
| nsc-6116 |
| nsc39967 |
| nsc-39967 |
| brn 2208105 |
| acetic acid, amide, n(3-chlorophenyl)- |
| einecs 209-610-3 |
| nsc 6116 |
| nsc 39967 |
| hsdb 1409 |
| meta-chloroacetanilide |
| inchi=1/c8h8clno/c1-6(11)10-8-4-2-3-7(9)5-8/h2-5h,1h3,(h,10,11 |
| AQ-012/40326599 |
| n-(3-chlorophenyl)acetamide |
| SR-01000636265-1 |
| MAYBRIDGE1_005393 |
| AKOS003108676 |
| HMS556N03 |
| CCG-46575 |
| unii-74h09hu61j |
| 74h09hu61j , |
| 4-12-00-01144 (beilstein handbook reference) |
| FT-0615446 |
| 3-chloroacetanilide [hsdb] |
| SCHEMBL357999 |
| EF-0227 |
| DTXSID6060420 |
| n-acetyl-3-chloroaniline |
| m-chloroacetoanilide |
| n-(3-chloro-phenyl)-acetamide |
| n-(3-chlorophenyl)acetamide # |
| n-(3-chlorophenyl)acetic acid amide |
| mfcd00016341 |
| Z28141013 |
| D84622 |
| Q27266276 |
| 3/'-chloroacetanilide |
| CS-0277313 |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 20.16
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 20.16 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.32 (4.65) | | Search Engine Demand Index | 15.26 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |